Ipsen has agreed to sell its rare pediatric disease priority review voucher to a large global pharmaceutical company for $158 million.

Managing IP features Orrick IP partner Irena Royzman for her impact in shaping patent protections for life sciences and tech clients.

Orrick intellectual property team behind tech and life sciences effort to reverse proposed U.S. Patent and Trademark Office rule

Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88 million funding round.

Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.